NASDAQ:SCLN - SciClone Pharmaceuticals Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $11.15 0.00 (0.00 %) (As of 02/17/2019 09:21 AM ET)Previous Close$11.15Today's Range$11.15 - $11.1552-Week Range$8.55 - $11.43VolumeN/AAverage Volume444,833 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email SciClone Pharmaceuticals, Inc. is a pharmaceutical company. The Company's product portfolio of therapies includes oncology, infectious diseases and cardiovascular disorders. The Company's business is focused primarily in the People's Republic of China. The Company operates in two segments: China and the Rest of the World, including its operations in the United States and Hong Kong. The Company's lead product ZADAXIN (thymalfasin) is approved in over 30 countries, which is used for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV), and certain cancers according to the local regulatory approvals, and for use as an immune system enhancer. In addition to ZADAXIN, SciClone markets seven partnered and in-licensed products in China. The Company sells ZADAXIN in various international markets through its subsidiary, SciClone Pharmaceuticals International Ltd. (SPIL). Its development portfolio includes Angiomax, Loramyc, Neucardin, VIBATIV and Cleviprex. Receive SCLN News and Ratings via Email Sign-up to receive the latest news and ratings for SCLN and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryPharmaceuticals SectorN/A Current SymbolNASDAQ:SCLN Previous Symbol CUSIP80862K10 Webwww.sciclone.com Phone+1-650-3583456Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees570 Outstanding SharesN/AMarket CapN/A OptionableNot Optionable SciClone Pharmaceuticals (NASDAQ:SCLN) Frequently Asked Questions What is SciClone Pharmaceuticals' stock symbol? SciClone Pharmaceuticals trades on the NASDAQ under the ticker symbol "SCLN." Has SciClone Pharmaceuticals been receiving favorable news coverage? Media headlines about SCLN stock have been trending positive on Sunday, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. SciClone Pharmaceuticals earned a daily sentiment score of 2.4 on InfoTrie's scale. They also gave media headlines about the specialty pharmaceutical company a news buzz of 6.0 out of 10, indicating that recent press coverage is somewhat likely to have an effect on the stock's share price in the near future. Who are SciClone Pharmaceuticals' key executives? SciClone Pharmaceuticals' management team includes the folowing people: Jon S Saxe, Independent Chairman of the BoardFriedhelm Blobel Ph.D., President, Chief Executive Officer, DirectorWilson W. Cheung, Chief Financial Officer, Senior Vice President - Finance, SecretaryHong Zhao, Chief Executive Officer - China OperationsRaymond Anthony Low CPA, Vice President - Finance, ControllerLan Xie CPA, Vice President - Finance, China Chief Financial OfficerNancy T. Chang Ph.D., Independent DirectorRichard James Hawkins, Independent DirectorAnthony Gregg Lapointe, Independent DirectorSimon Li, Independent Director How do I buy shares of SciClone Pharmaceuticals? Shares of SCLN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is SciClone Pharmaceuticals' stock price today? One share of SCLN stock can currently be purchased for approximately $11.15. What is SciClone Pharmaceuticals' official website? The official website for SciClone Pharmaceuticals is http://www.sciclone.com/. How can I contact SciClone Pharmaceuticals? SciClone Pharmaceuticals' mailing address is 950 Tower Ln Ste 900, FOSTER CITY, CA 94404-2125, United States. The specialty pharmaceutical company can be reached via phone at +1-650-3583456. MarketBeat Community Rating for SciClone Pharmaceuticals (NASDAQ SCLN)Community Ranking: 2.8 out of 5 ( )Outperform Votes: 178 (Vote Outperform)Underperform Votes: 140 (Vote Underperform)Total Votes: 318MarketBeat's community ratings are surveys of what our community members think about SciClone Pharmaceuticals and other stocks. Vote "Outperform" if you believe SCLN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SCLN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/17/2019 by MarketBeat.com StaffFeatured Article: Trading Options- What is a Strangle?